Ann L. MacDougall - Jun 15, 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Ann L. MacDougall
Stock symbol
OPNT
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 04:06 PM
Previous filing
May 13, 2021
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Award $0 +2K +9.44% $0.00 23.2K Jun 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPNT Stock Option (right to buy) Award $0 +2.5K $0.00 2.5K Jun 15, 2021 Common Stock 2.5K $13.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.
F2 On June 15, 2021, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.